Concordance of PCR and culture from nasal swabs for detection of methicillin-resistant staphylococcus aureus in a setting of concurrent antistaphylococcal antibiotics

Journal of Clinical Microbiology

Volumn 52, Issue 4, 2014, Pages 1235-1237

  Shenoy, Erica S ^a,b   Noubary, Farzad ^b,c,d   Kim, JiYeon ^a,b   Rosenberg, Eric S ^a,b   Cotter, Jessica A ^a   Lee, Hang ^a,b   Walensky, Rochelle P ^a,b   Hooper, David C ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; LEVOFLOXACIN; LINEZOLID; NITROFURANTOIN; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; COMPARATIVE STUDY; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NOSE MUCOSA; POLYMERASE CHAIN REACTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NASAL MUCOSA; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS;

EID: 84897130456     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02972-13     Document Type: Article

References (12)

1. Jarvis WR, Jarvis AA, Chinn RY. 2012. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. Am. J. Infect. Control 40:194-200. http://dx.doi.org/10.1016/j.ajic.2012.02.001.
2. Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA, Jr. 2008. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann. Emerg. Med. 51:291-298. http://dx.doi.org/10.1016/j.annemergmed.2007.12.004.
3. Landrum ML, Neumann C, Cook C, Chukwuma U, Ellis MW, Hospenthal DR, Murray CK. 2012. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 308:50-59. http://dx.doi.org/10.1001/jama.2012.7139.
4. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Health Care Infection Control Practices Advisory Committee. 2007. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am. J. Infect. Control 35:S65-S164. http://dx.doi.org/10.1016/j.ajic. 2007.10.007. (Pubitemid 350213178)
5. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Health Care Infection Control Practices Advisory Committee. 2007. Management of multi-drug-resistant organisms in health care settings, 2006. Am. J. Infect. Control 35:S165-93. http://dx.doi.org/10.1016/j.ajic.2007.10.006. (Pubitemid 350225593)
6. Shenoy ES, Hsu H, Noubary F, Hooper DC, Walensky RP. 2012. National survey of infection preventionists: policies for discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus. Infect. Control Hosp. Epidemiol. 33:1272-1275. http://dx.doi.org/10.1086/668427;10.1086/668427.
7. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, Zuravleff JJ. 1986. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N. Engl. J. Med. 315:91-96. http://dx.doi.org/10.1056/NEJM198607103150204. (Pubitemid 16093211)
8. Keene A, Vavagiakis P, Lee MH, Finnerty K, Nicolls D, Cespedes C, Quagliarello B, Chiasson MA, Chong D, Lowy FD. 2005. Staphylococcus aureus colonization and the risk of infection in critically ill patients. Infect. Control Hosp. Epidemiol. 26:622-628. http://dx.doi.org/10.1086/502591. (Pubitemid 41073402)
9. Ellis MW, Griffith ME, Dooley DP, McLean JC, Jorgensen JH, Patterson JE, Davis KA, Hawley JS, Regules JA, Rivard RG, Gray PJ, Ceremuga JM, Dejoseph MA, Hospenthal DR. 2007. Targeted intranasal mupirocin to prevent colonization and infection by communityassociated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob. Agents Chemother. 51:3591-3598. http://dx.doi.org/10.1128/AAC.01086-06. (Pubitemid 47519348)
10. Shenoy E, Kim J, Rosenberg E, Cotter J, Lee H, Walensky R, Hooper D. 2013. Discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus (MRSA): a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. Clin. Infect. Dis. 57:176-184. http://dx.doi.org/10.1093/cid/cit206.
11. Paule SM, Mehta M, Hacek DM, Gonzalzles TM, Robicsek A, Peterson LR. 2009. Chromogenic media vs real-time PCR for nasal surveillance of methicillin-resistant Staphylococcus aureus: impact on detection of MRSA-positive persons. Am. J. Clin. Pathol. 131:532-539. http://dx.doi.org/10. 1309/AJCP18ONZUTDUGAQ.
12. Wolk DM, Picton E, Johnson D, Davis T, Pancholi P, Ginocchio CC, Finegold S, Welch DF, de Boer M, Fuller D, Solomon MC, Rogers B, Mehta MS, Peterson LR. 2009. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J. Clin. Microbiol. 47:758-764. http://dx.doi.org/10.1128/JCM. 01714-08.